Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

K L Yong

Showing results (21-30 of 27) with videos related to

Pageof 3
Sort By:
You have reached the last page of results.This site can display upto 27 results.
European Journal of Haematology|January 1, 1993
Pentoxifylline at clinically achievable levels inhibits FMLP-induced neutrophil responses, but not priming, upregulation of cell-adhesion molecules, or migration induced by GM-CSFP J Roberts, K L Yong, A Khwaja, et al.
Annals of the Academy of Medicine, Singapore|April 7, 2009
Geographic-time distribution of ambulance calls in Singapore: utility of geographic information system in ambulance deployment (CARE 3)Marcus E H Ong, Faith S P Ng, Jerry Overton, et al.
Immunology|February 1, 1997
Selective migration of highly differentiated primed T cells, defined by low expression of CD45RB, across human umbilical vein endothelial cells: effects of viral infection on transmigrationN J Borthwick, A N Akbar, L P MacCormac, et al.
Leukemia|July 28, 2007
A new xenograft model of myeloma bone disease demonstrating the efficacy of human mesenchymal stem cells expressing osteoprotegerin by lentiviral gene transferN Rabin, C Kyriakou, L Coulton, et al.
Lancet (London, England)|July 9, 1988
Alpha-interferon therapy for essential thrombocythaemiaF J Giles, C R Singer, A G Gray, et al.
Annals of the Academy of Medicine, Singapore|October 6, 2005
An intelligent tutoring system for trauma management (Trauma-Teach): a preliminary reportL S Ong, A Vijayan, C S Koh, et al.
Leukemia|July 16, 2016
A randomized phase III study of carfilzomib vs low-dose corticosteroids with optional cyclophosphamide in relapsed and refractory multiple myeloma (FOCUS)R Hájek, T Masszi, M T Petrucci, et al.
Pageof 3

Showing results (21-30 of 27) with videos related to

Sort By:
Pageof 3
You have reached the last page of results.This site can display upto 27 results.
European Journal of Haematology|January 1, 1993
Pentoxifylline at clinically achievable levels inhibits FMLP-induced neutrophil responses, but not priming, upregulation of cell-adhesion molecules, or migration induced by GM-CSFP J Roberts, K L Yong, A Khwaja, et al.
Annals of the Academy of Medicine, Singapore|April 7, 2009
Geographic-time distribution of ambulance calls in Singapore: utility of geographic information system in ambulance deployment (CARE 3)Marcus E H Ong, Faith S P Ng, Jerry Overton, et al.
Immunology|February 1, 1997
Selective migration of highly differentiated primed T cells, defined by low expression of CD45RB, across human umbilical vein endothelial cells: effects of viral infection on transmigrationN J Borthwick, A N Akbar, L P MacCormac, et al.
Leukemia|July 28, 2007
A new xenograft model of myeloma bone disease demonstrating the efficacy of human mesenchymal stem cells expressing osteoprotegerin by lentiviral gene transferN Rabin, C Kyriakou, L Coulton, et al.
Lancet (London, England)|July 9, 1988
Alpha-interferon therapy for essential thrombocythaemiaF J Giles, C R Singer, A G Gray, et al.
Annals of the Academy of Medicine, Singapore|October 6, 2005
An intelligent tutoring system for trauma management (Trauma-Teach): a preliminary reportL S Ong, A Vijayan, C S Koh, et al.
Leukemia|July 16, 2016
A randomized phase III study of carfilzomib vs low-dose corticosteroids with optional cyclophosphamide in relapsed and refractory multiple myeloma (FOCUS)R Hájek, T Masszi, M T Petrucci, et al.
Pageof 3